Inducible Nitric Oxide Synthase Mediates Retinal Apoptosis in Ischemic Proliferative Retinopathy

Journal of Neuroscience

Volumn 22, Issue 10, 2002, Pages 3987-3993

  Sennlaub, Florian ^a,b,c   Courtois, Yves ^a   Goureau, Olivier ^a  

^a BICHAT HOSPITAL   (France)

^b HUMBOLDT UNIVERSITY   (Germany)

^c INSERM   (France)

Author keywords

Apoptosis; Inducible nitric oxide synthase; Ischemia; Knock out mice; Neovascularization; Peroxynitrite; Retina; ROP

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; 3 NITROTYROSINE; 3-NITROTYROSINE; AMIDINE; BENZYLAMINE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; N (3 (AMINOMETHYL)BENZYL)ACETAMIDINE; N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE; NOS2 PROTEIN, MOUSE; OXYGEN; PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA DEGENERATION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; AGING; ANIMAL; CELL COUNT; CROSS BREEDING; DIABETIC RETINOPATHY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; NEWBORN; NICK END LABELING; PATHOLOGY; RETINA; RETINA DISEASE; RETINA VEIN OCCLUSION;

AGING; AMIDINES; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BENZYLAMINES; CELL COUNT; CROSSES, GENETIC; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISCHEMIA; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PROTEINS; RETINA; RETINAL DISEASES; RETINAL VEIN OCCLUSION; TYROSINE;

EID: 0037095765     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-10-03987.2002     Document Type: Article

References (35)

1. Adamis AP, Aiello LP, D'Amato RA (1999) Angiogenesis and ophthalmic disease. Angiogenesis 3:9-14.
2. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
3. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, Stuehr DJ (2001) Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA 98:12056-12061.
4. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791.
5. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
6. Bek T (1994) Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol 72:409-415.
7. Bolanos JP, Almeida A, Fernandez E, Medina JM, Land JM, Clark JB, Heales SJ (1997) Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism. Biochem Soc Trans 25:944-949.
8. Brune B, von Knethen A, Sandau KB (1998) Nitric oxide and its role in apoptosis. Eur J Pharmacol 351:261-272.
9. Christopherson KS, Bredt DS (1997) Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 100:2424-2429.
10. Collier A, Mitchell JD, Clarke BF (1985) Visual evoked potential and contrast sensitivity function in diabetic retinopathy. Br Med J Clin Res 291:248.
11. D'Amore PA (1994) Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci 35:3974-3979.
12. Dembinska O, Rojas LM, Varma DR, Chemtob S, Lachapelle P (2001) Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci 42:1111-1118.
13. El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551-556.
14. Fulton AB, Hansen RM (1996) Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A 13:566-571.
15. Fulton AB, Hansen RM, Petersen RA, Vanderveen DK (2001) The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol 119:499-505.
16. Garban HJ, Bonavida B (2001) Nitric oxide inhibits the transcription repressor yin-yang 1 binding activity at the silencer region of the fas promoter: a pivotal role for nitric oxide in the up-regulation of fas gene expression in human tumor cells. J Immunol 167:75-81.
17. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963.
18. Geyer O, Almog J, Lupu-Meiri M, Lazar M, Oron Y (1995) Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett 374:399-402.
19. Goureau O, Regnier-Ricard F, Courtois Y (1999) Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells. J Neurochem 72:2506-2515.
20. Greenacre SA, Ischiropoulos H (2001) Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 34:541-581.
21. Halliwell B, Zhao K, Whiteman M (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31:651-669.
22. Lachapelle P, Dembinska O, Rojas LM, Benoit J, Almazan G, Chemtob S (1999) Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia. Can J Physiol Pharmacol 77:48-55.
23. Lam TT, Abler AS, Tso MO (1999) Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Invest Ophthalmol Vis Sci 40:967-975.
24. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell [Erratum (1995) 81:1170] 81:641-650.
25. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350.
26. MacMillan-Crow LA, Thompson JA (1999) Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys 366:82-88.
27. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-2423.
28. Palmowski AM, Sutter EE, Bearse Jr MA, Fung W (1997) Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci 38:2586-2596.
29. Penn JS, Rajaratnam VS, Collier RJ, Clark AF (2001) The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42:283-290.
30. Reisner DS, Hansen RM, Findl O, Petersen RA, Fulton AB (1997) Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci 38:1175-1183.
31. Sennlaub F, Courtois Y, Goureau O (2001) Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest 107:717-725.
32. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
33. Sun D, Coleclough C, Cao L, Hu X, Sun S, Whitaker JN (1998) Reciprocal stimulation between TNF-alpha and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J Neuroimmunol 89:122-130.
34. Wolter JR (1961) Diabetic retinopathy. Am J Ophthalmol 51:1123-1139.
35. Yamakura F, Taka H, Fujimura T, Murayama K (1998) Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 273:14085-14089.